Plants use the same set of co-receptors to mediate distinct responses to external signals. Brassinosteroid signaling serves as a test case to unravel the mechanisms of receptor-co-receptor activation and initiation of a specific signaling cascade.
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Plant growth and development are driven by a complex network of internal signals, including brassinosteroids (BRs), the polyhydroxylated steroid hormones of plants. Over the past decade, genetic and biochemical approaches have provided a wealth of information on BR perception and signaling, but the precise molecular mechanisms driving receptor complex activation and signal transduction to downstream 'actors' are still not fully understood [1] . Recent reports have elucidated how BR perception leads to sequential activation of the receptorco-receptor complex and have identified new BR signaling components acting directly downstream of the receptor.
Unlike animal steroid hormones, which are mostly perceived by the nuclear receptor family of transcription factors, BRs bind directly to the extracellular domain of BRI1, a leucine-rich repeat receptor-like kinase (LRR-RLK) that is localized to the plasma membrane [2] . Binding of BRs to pre-existing BRI1 homo-oligomers leads to BRI1 autophosphorylation and to transphosphorylation of the LRR-RLK BAK1/SERK3 [3] [4] [5] [6] . Unexpectedly, BAK1, together with other homologs of the SERK subfamily, was recently shown to regulate cell death and to function in multiple pathogenassociated molecular pattern (PAMP) responses, including responses to flagellin, EF-Tu, bacterial cold-shock protein, and oomycete elicitor INF1, that serve as the first line of defense against pathogens [7] [8] [9] [10] . Analogous to its interaction with BRI1, BAK1 was shown to rapidly associate with the LRR-RLK flagellin-binding receptor FLS2 shortly after ligand stimulation [7] . However, BAK1 binds neither BRs nor flagellin [6, 7] . Instead, BAK1 appears to act as a general co-receptor of the main ligand-binding receptor, together likely forming a signaling-competent hetero-oligomer. Interestingly, BAK1 has also been shown to promote BRI1 and FLS2 internalization into endosomes [11, 12] , reminiscent of ligand-induced activation, multimerization and internalization of animal single-pass transmembrane receptors. Therefore, it is unclear whether BAK1's main function is to activate the ligand-binding receptor, to bridge the receptor with downstream components, or to promote receptor endocytosis.
To crack the code of BR receptor complex activation, Wang and colleagues [13] thoroughly dissected, in vitro and in vivo, the sequential mechanisms leading to BRI1 and BAK1 phosphorylation, and how differential receptor activation correlates with signaling. This interesting study revealed that BRI1 acts independently of its co-receptor BAK1 to bind its ligand, to initiate kinase activation and to sustain basal BR signaling and responses, as visualized by the elongation of the hypocotyl (the plant embryonic stem). However, full BR responses arise from the association between activated BRI1 and BAK1 and subsequent transphosphorylation of BAK1's activation loop residues. Activated BAK1, in turn, transphosphorylates BRI1 in the juxtamembrane and carboxy-terminal domains, leading to enhanced BRI1 kinase activity and BR signaling ( Figure 1A ). More importantly, the authors provide the first framework for grasping how differential phosphorylation of BAK1 by associated ligand-binding receptor kinases likely explains its participation in different signaling pathways. Notably, BAK1 residue T450 is phosphorylated by BRI1 in vitro and, presumably, in vivo, but mutation of the corresponding residue does not affect the various BAK1-dependent signaling pathways to the same extent. Indeed, phenotypic analysis of plants expressing a T450A non-phosphorylatable BAK1 mutant version revealed that phosphorylation at this BAK1 residue may be important to activate BRI1 and especially FLS2 but may not be required for cell death regulation. A comparative analysis of BAK1 in vivo phosphorylation sites in BR versus flagellin-treated plants is needed to shed additional light on the phosphorylated residues leading to differential BAK1 activation by BRI1 and FLS2 and, in turn, on the role of BAK1 in the subsequent activation of different LRR-RLKs. Does BAK1 have other roles besides just activating the ligand-binding receptor? How about the role of BAK1 in receptor endocytosis? One would expect to observe ligand-dependent receptor endocytosis considering that BAK1 associates with the main receptor upon ligand binding. While this scenario fits well with the data obtained for FLS2 [7, 11] , a recent study elegantly demonstrated that BRI1 is endocytosed in a BR-independent manner [14] . Further conclusions on the role of BAK1 in endocytosis of BRI1 will await a detailed analysis of BRI1 internalization in bak1 mutant plants.
As [1] . Why is this so? From these past unsuccessful attempts we can deduce that the relevant genes are either functionally redundant or that the loss of their functions results in lethality. Searches for BRI1-interacting proteins have identified several potential actors, although their in vivo role in BR signaling is not well understood. Only the BRI1-kinase interactor BKI1 has been shown to limit BRI1 and BAK1 interaction to prevent receptor activation in the absence of BRs [15] . In a recent report, Tang and colleagues [16] identified the BSK receptor-like cytosolic kinases as new BRI1 substrates. BSK1 interacts in vivo with plasma-membrane-localized BRI1, with BRs decreasing their association ( Figure 1A) . Loss-and gain-of-function genetic analyses of some BSK family members suggest that they are positive regulators of BR signaling, acting upstream of BIN2. A model emerges in which BSKs might be released from the receptor upon phosphorylation by BRI1 to transduce the signal to downstream components. Again, BAK1 turns out to be unable to interact with BSKs, further supporting the hypothesis that BR signaling to downstream actors initiates from BRI1. Whether BIN2, whose plasma membrane localization has already been documented [17] , is a substrate of BSK kinase activity remains an open question in this 'grail quest' for the missing downstream factors.
While the puzzle of the core BR signaling cascade rapidly assembles, its interaction with other pathways has slowly come to light. Not only do BR and defense signaling pathways share BAK1 [3, 4, 7, 9] , but recent work from Shan and colleagues [18] Cognitive Neuroscience: Searching for the Bottleneck in the Brain People simply cannot do two things at once, as shown by research on the so-called psychological refractory period. A new neuroimaging study has now localized the response-selection bottleneck underlying the psychological refractory period to a frontoparietal network.
Charles Spence
The notion that dual-task performance in humans is fundamentally constrained by some kind of internal bottleneck goes back more than half a century to the pioneering early work of Kenneth Craik, Alan Welford, and Margaret Vince [1, 2] . In recent years, most research on this topic has been conducted within the framework of the 'psychological refractory period' -the interference (or delay) in responding to the second of two stimuli that is observed when they are presented close together in time. Hal Pashler and his colleagues [3, 4] have published an impressive number of behavioral studies on the psychological refractory period showing, time-and-again, that people simply cannot perform two tasks at once, no matter how much
